Evommune, Inc. (EVMN) — Stock Score Summary

Evommune, Inc. (EVMN) has a MoatMap StockRank of 13/100 based on Quality (32/100), Value (37/100), and Momentum (28/100) factor scores. The current signal is STRONG SELL. A clinical-stage immunology biotech with no commercial products, high cash burn, and binary regulatory risks, completely outside our quality mandate.

Evommune, Inc. is a clinical-stage biotechnology company dedicated to developing novel therapies for chronic inflammatory and autoimmune diseases. The company's pipeline targets key immunological pathways, utilizing small molecule inhibitors to address unmet medical needs in dermatology and immunology. Its competitive edge lies in its proprietary drug discovery platform and a leadership team with a proven track record of developing blockbuster immunology drugs.

Key Financial Metrics

Price$20.49
Market Cap$840M
P/E (Forward)-5.84
Price/Book2.30
Return on Equity-45.0%
Return on Invested Capital-39.2%
Debt/Equity2.99
Gross Margin100.0%
Operating Margin-899.9%
Free Cash Flow$-58M

Evommune, Inc. operates in the Biotechnology industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is Evommune, Inc.’s (EVMN) StockRank?
MoatMap’s StockRank for Evommune, Inc. (EVMN) is 13/100, with a Strong Sell signal. It is a composite of Quality (32), Value (37), and Momentum (28) factor ranks across MoatMap’s 19,000+ stock universe.
Does Evommune, Inc. have an economic moat?
Evommune, Inc. (EVMN) has a Quality factor score of 32/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Evommune, Inc. a buy, hold, or sell?
MoatMap’s current signal for Evommune, Inc. (EVMN) is Strong Sell, based on a StockRank of 13/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Evommune, Inc. in?
Evommune, Inc. (EVMN) operates in the Healthcare sector, specifically the Biotechnology industry (United States).
Browse all ranked stocksEVMN deep dive reportAI ChampionsHow we score stocksSense-check another stock